Weight Loss News and Research

Latest Weight Loss News and Research

Prescription trends for obesity medications surge, tied to growing interest in GLP-1 drugs

Obesity medication prescriptions reached 1.5 million, driven by GLP-1 agents semaglutide and tirzepatide, as public interest influences prescription trends.

3 Feb 2025

TBorNotTB: A novel AI-driven tool to streamline tuberculosis evaluation in hospitals

This study presents TBorNotTB, a CDSS designed to improve TB evaluation and streamline isolation decisions, reducing labor while maintaining detection accuracy.

31 Jan 2025

Revolutionizing diabetes care with innovative targets and therapeutic options

A thorough examination of modern drugs that target particular receptors and metabolic pathways for glucose and fat metabolism is presented. Recent research has revealed innovative targets and therapeutic options.

30 Jan 2025

Telehealth companies boost ad spending while taking on more complex medicine

Shannon Sharpe was having one of those 15-minutes-of-internet-infamy moments. Social media blew up in September after the retired Denver Broncos tight end — accidentally, he later said — broadcast some of his intimate activities online.

30 Jan 2025

Can an online lifestyle plan keep your brain sharp? Research says yes

"Maintain Your Brain" study shows how a tailored online program can improve cognition and lower dementia risk—discover how simple lifestyle changes could protect your brain as you age.

29 Jan 2025

Self-guided family-based treatment effective for childhood obesity

Family-based behavioral treatment (FBT) is a clinically-proven approach to treating children with obesity in which a health care professional works with the family to help children lose weight by promoting physical activity, encouraging healthy eating habits, and teaching age-appropriate behavioral skills.

29 Jan 2025

New compound Z526 combats cancer-associated cachexia in preclinical models

In a recent study, researchers demonstrated that Z526, a novel dithiocarbamate-like compound, mitigates cancer-associated cachexia (CAC) both in vitro and in vivo.

29 Jan 2025

Moderate exercise helps control appetite in obese men

A recent study involving researchers at Murdoch University's Health Futures Institute has revealed that moderate-intensity exercise can significantly influence appetite-related hormones and perceptions in males with obesity.

28 Jan 2025

Bariatric surgery reduces liver complications in obese patients with cirrhosis

A Cleveland Clinic study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future risk of developing serious liver complications compared with patients who received medical therapy alone.

27 Jan 2025

Dietary intervention restores gut microbiome and offers protection against chronic diseases

Findings indicate that a microbiome restoration diet improves gut health and reduces chronic disease markers, highlighting its cardiometabolic benefits.

27 Jan 2025

Online app supports weight loss through protein and fiber tracking

Many people struggle to maintain a healthy weight, and choosing the optimal meals for weight loss can be challenging.

24 Jan 2025

Dapagliflozin plus calorie restriction boosts remission rates in adults with type 2 diabetes and obesity

Findings indicate that dapagliflozin and calorie restriction together improve weight loss and metabolic health, increasing the likelihood of diabetes remission.

24 Jan 2025

Boosting BCL6 may counteract muscle loss from GLP-1 medications

About one in eight adults in the United States has tried or currently uses a GLP-1 medication, and a quarter of those users cite weight loss as their main goal.

23 Jan 2025

Non-industrialized diet improves health and reduces disease risk

Researchers have found that a newly developed diet inspired by the eating habits of non-industrialised societies can significantly reduce the risk of a number of chronic diseases – and are to share recipes with the public.

23 Jan 2025

What causes behavioral side effects in popular weight loss drugs?

The study of GLP1R variants shows associations with cardiometabolic traits and behavioral changes, highlighting indirect effects of GLP1RA on mental health.

23 Jan 2025

Dapagliflozin and calorie restriction show higher remission rates in type 2 diabetes

Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin alongside moderate calorie restriction achieve much higher rates of remission compared with calorie restriction alone, finds a trial published by The BMJ today.

23 Jan 2025

GLP1RA medications linked to behavioral side effects in type 2 diabetes and obesity

Glucagon-like peptide 1 receptor agonists (GLP1RA)-medications for type 2 diabetes and obesity that have recently been making headlines due to a rise in popularity as weight loss agents-have been linked with behavioral side effects.

22 Jan 2025

Fizzy water may aid weight loss but can't replace healthy lifestyle

Fizzy water might aid weight loss by boosting blood glucose uptake and metabolism-the rate at which the body uses and converts energy-but the effects are so small, drinking it can't be relied on alone to shed the pounds, concludes a brief analysis published in the open access journal BMJ Nutrition Prevention & Health.

21 Jan 2025

Childhood obesity treatment reduces long-term health risks but not depression

When children with obesity undergo weight-loss treatment, the effects have repercussions later in life and the risk of serious health problems and premature death is lower as they reach young adulthood.

21 Jan 2025

Benefits and risks of popular weight-loss drugs revealed

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study reporting one in eight Americans has taken or is currently using the drugs to treat diabetes, heart disease or obesity.

20 Jan 2025

Weight Loss News and Research

Latest Weight Loss News and Research

Prescription trends for obesity medications surge, tied to growing interest in GLP-1 drugs

TBorNotTB: A novel AI-driven tool to streamline tuberculosis evaluation in hospitals

Revolutionizing diabetes care with innovative targets and therapeutic options

Telehealth companies boost ad spending while taking on more complex medicine

Can an online lifestyle plan keep your brain sharp? Research says yes

Self-guided family-based treatment effective for childhood obesity

New compound Z526 combats cancer-associated cachexia in preclinical models

Moderate exercise helps control appetite in obese men

Bariatric surgery reduces liver complications in obese patients with cirrhosis

Dietary intervention restores gut microbiome and offers protection against chronic diseases

Online app supports weight loss through protein and fiber tracking

Dapagliflozin plus calorie restriction boosts remission rates in adults with type 2 diabetes and obesity

Boosting BCL6 may counteract muscle loss from GLP-1 medications

Non-industrialized diet improves health and reduces disease risk

What causes behavioral side effects in popular weight loss drugs?

Dapagliflozin and calorie restriction show higher remission rates in type 2 diabetes

GLP1RA medications linked to behavioral side effects in type 2 diabetes and obesity

Fizzy water may aid weight loss but can't replace healthy lifestyle

Childhood obesity treatment reduces long-term health risks but not depression

Benefits and risks of popular weight-loss drugs revealed

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Weight Loss News and Research

Latest Weight Loss News and Research

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in